Clinical Trial Update: Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20) [Phase 2]

View source ↗

Summary

Phase 2 trial update on immune effects of oral insulin in relatives at risk for type 1 diabetes; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Oral insulin (insulin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2020-07-27